Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Sue Siegel, Mike Barber, Stephen Fodor, Frank Witney, Nelson Chan, and More

Premium

GE has named Sue Siegel to serve as CEO of its Healthymagination initiative.

Siegel joins GE from Mohr Davidow Ventures. Prior to that, she was president of Affymetrix. She takes over the CEO role from Mike Barber, who led the initiative since 2009 but has since been named vice president and general manager of molecular imaging at GE Healthcare.


All eight of Affymetrix's nominees have been elected to its board of directors by the firm's shareholders. The board includes Stephen Fodor, Frank Witney, Nelson Chan, John Diekman, Gary Guthart, Jami Dover Nachtsheim, Robert Trice, and Robert Wayman.

Fodor is founder and executive chairman of the firm, while Witney is CEO and president. Wayman was elected by the independent directors to serve as lead director.


HTG Molecular Diagnostics has hired Chris Roberts to serve as vice president of medical innovation. Roberts joins HTG from Caris Life Science, where he was VP of the oncology division. Previous to that, he worked at Ventana Medical Systems as a director in the molecular diagnostic and strategic marketing divisions.

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.